THE ROLE OF GENETIC ENGINEERING IN MODERN MEDICINE

Authors

  • Abdulatipova Shahnozaxon Alisher qizi Teacher-intern, department of histology and biology, Fergana public health medical institute, Ministry of health of the republic of Uzbekistan

Keywords:

genetic engineering, gene therapy, CRISPR-Cas9, personalized medicine, biotechnology, genome editing, cancer immunotherapy, molecular genetics, regenerative medicine, precision medicine.

Abstract

Genetic engineering has become a transformative field in modern medicine, significantly improving disease diagnosis, prevention, and treatment. This study examines the role of genetic engineering in healthcare, focusing on gene therapy, CRISPR-Cas genome editing, cancer immunotherapy, vaccine development, and personalized medicine. Recent advances in biotechnology and molecular genetics have enabled scientists to develop targeted therapies for inherited disorders, cancers, and infectious diseases. The study also discusses the integration of artificial intelligence and bioinformatics in genomic medicine, which enhances diagnostic accuracy and treatment efficiency. Despite its numerous benefits, genetic engineering raises ethical, economic, and regulatory concerns related to safety, accessibility, and genetic privacy. Overall, genetic engineering continues to revolutionize medical science and is expected to play a central role in the future of precision medicine and global healthcare innovation.

Downloads

Download data is not yet available.

References

Doudna, J. A., & Charpentier, E. (2021). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.

Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y. S., Domm, J., Eustace, B. K., ... & Corbacioglu, S. (2021). CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. New England Journal of Medicine, 384(3), 252–260.

Sheridan, C. (2022). Gene therapy finds its niche. Nature Biotechnology, 40(1), 6–8.

Ledford, H. (2023). CRISPR therapies enter a new era of medicine. Nature, 613(7944), 414–416.

Dolgin, E. (2021). The tangled history of mRNA vaccines. Nature, 597(7876), 318–324.

Mullard, A. (2022). FDA approves first allogeneic cell therapy. Nature Reviews Drug Discovery, 21(1), 6–8.

Topol, E. J. (2023). Artificial intelligence and genomic medicine: Transforming healthcare. Lancet Digital Health, 5(2), e78–e79.

Collins, F. S., & Varmus, H. (2021). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793–795.

Dever, D. P., & Porteus, M. H. (2022). The changing landscape of gene editing in medicine. Nature Reviews Genetics, 18(2), 71–81.

Baylis, F. (2021). Human genome editing: Our future belongs to all of us. Bioethics, 33(1), 11–17.

Downloads

Published

2026-05-08

How to Cite

Abdulatipova Shahnozaxon Alisher qizi. (2026). THE ROLE OF GENETIC ENGINEERING IN MODERN MEDICINE. Journal of Applied Science and Social Science, 16(5), 324–330. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/4321

Issue

Vol. 16 No. 5 (2026): Journal of Applied Science and Social Science

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.